Skip to main content

Together we are beating cancer

Donate now

Genomics

Showing 4 out of 4 results
A computer-generated image showing a DNA double-helix in a blood sample

Precision medicine is transforming cancer care. We explore how liquid biopsies could help bring it to more patients more quickly. Precision medicine is transforming cancer care. We explore how liquid biopsies could help bring it to more patients more quickly.

by Jessica Lloyd, Elizabeth Owen | In depth | 16 April 2025

16 April 2025

This entry is part 4 of 4 in the series Multi-cancer tests
A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

Lab-grown bowel cancer cells seen through a microscope. They are colour-enhanced and appear blue.

A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists.  A new testing technique with genome sequencing is 90% accurate at predicting which high-risk people with IBD will develop bowel cancer, according to a study by our scientists. 

by Tim Gunn | News | 30 January 2025

30 January 2025

A group of three female Cancer Research UK scientists working with samples at a lab bench. They are smiling, talking and wearing lab coats.

Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play. Alice Hilborn, policy advisor at Cancer Research UK, sits down with David Wells, chief executive at the Institute of Biomedical Science (IBMS), to understand the views of the IBMS on the future of genomic medicine, and the role healthcare scientists could play.

by Alice Hilborn | Opinion | 10 December 2024

10 December 2024